dutasteride for BPH
Selected indexed studies
- Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review. (Gerontology, 2019) [PMID:30943489]
- Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride? (Curr Drug Targets, 2015) [PMID:25981606]
- Comparison of Serenoa repens, lycopene, and selenium versus dutasteride for the treatment of LUTS/BPH: an Italian multicenter case-control prospective study (COMP study). (Front Urol, 2025) [PMID:40777606]
_Worker-drafted node — pending editorial review._
Connections
dutasteride for BPH is a side effect of
Sources
- Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review. (2019) pubmed
- Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride? (2015) pubmed
- Comparison of Serenoa repens, lycopene, and selenium versus dutasteride for the treatment of LUTS/BPH: an Italian multicenter case-control prospective study (COMP study). (2025) pubmed
- Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride. (2021) pubmed
- Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis. (2014) pubmed
- Tamsulosin and Dutasteride Combination Therapy for Asian Men With Moderate-to-Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review of Clinical Considerations That Influence the Prescription. (2024) pubmed
- Dutasteride. (2026) pubmed
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm. (2020) pubmed
- Finasteride Use: Evaluation of Depression and Suicide Risk. (2025) pubmed
- The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. (2010) pubmed